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Background: Health services research is expected to involve service users as active partners in the research process,
but few examples report how this has been achieved in practice in trials. We implemented a model to involve
service users in a multi-centre randomised controlled trial in pre-hospital emergency care. We used the generic
Standard Operating Procedure (SOP) from our Clinical Trials Unit (CTU) as the basis for creating a model to fit the
context and population of the SAFER 2 trial.
Methods: In our model, we planned to involve service users at all stages in the trial through decision-making forums
at 3 levels: 1) strategic; 2) site (e.g. Wales; London; East Midlands); 3) local. We linked with charities and community
groups to recruit people with experience of our study population. We collected notes of meetings alongside other
documentary evidence such as attendance records and study documentation to track how we implemented our
model.
Results: We involved service users at strategic, site and local level. We also added additional strategic level forums (Task
and Finish Groups and Writing Days) where we included service users. Service user involvement varied in frequency
and type across meetings, research stages and locations but stabilised and increased as the trial progressed.
Conclusion: Involving service users in the SAFER 2 trial showed how it is feasible and achievable for patients, carers
and potential patients sharing the demographic characteristics of our study population to collaborate in a multi-centre
trial at the level which suited their health, location, skills and expertise. A standard model of involvement can be tailored
by adopting a flexible approach to take account of the context and complexities of a multi-site trial.
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There is increased expectation that people who use
health and care services should be involved in research
including trials, but little evidence that this is happening
in practice. Though service user involvement in health
services research is growing, the majority of studies in
which service users are involved are qualitative, rather
than trials [1–3].
UK government policy requires involvement by service
users in all research undertaken through the National
Health Service (NHS) [4–8] and most national and inter-
national research funding programmes expect service
users to be involved in the development and conduct of
studies which are submitted to them [9–11]. The network
of UK Clinical Trials Units encourages service users to
work with researchers in designing and undertaking trials
(see http://www.ukcrc-ctu.org.uk/?page=Patients).
Service user involvement in research has been defined
as research carried out ‘with’ or ‘by’ members of the
public rather than ‘to’, ‘about’ or ‘for’ them [12]. Involv-
ing service users in research is encouraged to improve
relevance, quality and accountability of research [12–16].
Guidelines recommend ways to enhance involvement
to support effective input from service users and im-
prove opportunities for positive impacts on research
[17–19]. Guidance has also been published to support
their involvement in trials [20]. Researchers are advised
to adopt a flexible approach to facilitate and enhance in-
volvement, by considering ‘different approaches within
the same trial or group of trials, involving different
people in different ways at different stages’ [21]. Involve-
ment can take place at all research stages through con-
sultation, collaboration or by service users leading the
research [12].
A systematic review published in 2011 identified only
9 studies reporting service user involvement in the de-
sign and conduct of clinical trials. Challenges reported
in these trials included: identifying service users who
were representative of trial participants, particularly
people who were older and frail; facilitating public un-
derstanding of trial methodology; and ensuring a partici-
patory framework which enabled active involvement
within trial resources [22]. A bibliometric literature re-
view identified the most common health topic research
areas to involve service users as: mental health; health of
black, minority, ethnic and indigenous groups; children
and parenting. In contrast, the health of older people was
found to be among the research topics least likely to in-
volve service users [2]. Additionally, no reviews have iden-
tified studies reporting the involvement of service users in
pre-hospital and emergency care research [2, 23, 24].
Factors which enhance the quality and impact of service
user involvement in research include: clarifying the role of
service users; acknowledging their skills, knowledge andexperience; providing support, information and resources
to enable involvement; involving people at an appropriate
level; describing and acknowledging service user involve-
ment in study reports [25, 26]. It is challenging to involve
service users who are harder to reach because of illness,
age, cultural background or geography [27]. Researchers
can endeavour to ensure that involvement is accessible to
all by targeted recruitment and addressing barriers caused
by lack of mobility, income, information and skills [28].
The SAFER 2 trial (Support and Assessment for Fall
Emergency Referrals) evaluated the clinical and cost-
effectiveness of referral to community-based falls ser-
vices by paramedics for older people who had fallen but
did not require care at the emergency department (ED)
[29]. The trial, funded by the National Institute of
Health Research Health Technology Assessment (NIHR
HTA) programme in response to an unsustainable rise
in emergency ambulance demand for non-life-
threatening emergencies, was a multi-centre pragmatic
cluster-randomised controlled trial (C-RCT) led from
Swansea University, with 25 participating ambulance sta-
tions across 3 study sites in Wales, London and East
Midlands.
As an NIHR-funded trial, SAFER 2 was required to en-
sure that members of the public were actively involved
throughout the research process. SAFER 2 was sup-
ported by the Swansea Clinical Trials Unit (CTU) which
developed, as one of its suite of Standard Operating Pro-
cedures (SOPs), a SOP for involving service users in tri-
als [20]. This SOP outlined roles and processes for
public involvement and recommended involving service
users in all trial decision-making forums, including spe-
cific recommendations for service user representation (a
minimum of two people) on structures such as the Trial
Development Group (TDG) and Trial Management
Group (TMG). The SOP also made recommendations
for support and remuneration to service user members
and was the basis for facilitating service user involve-
ment in the SAFER 2 trial. This paper describes how we
implemented a collaborative model to involve older
people in the SAFER 2 multi-centre trial of a complex
intervention in pre-hospital emergency care.
Methods
We took the Swansea CTU SOP for service user involve-
ment in trials [20] as our starting point. The SOP rec-
ommends levels of service user involvement in a trial at
strategic management level (such as TMG) and at local
management level. It also suggests researchers identify
opportunities for service user input through ad hoc task-
focused meetings. We considered that this approach re-
quired modification to suit the multi-centre structure of
our trial, which included site level (Wales, London, East
Midlands) and local levels of implementation (delivering
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outset, the study team agreed a plan. A researcher led its
implementation and oversaw site researchers who had
responsibility for service user involvement in their own
areas. Advice and guidance was provided by the CTU
Involvement Manager about developing and implement-
ing the model, recruiting and supporting service users.
Proposed structures of involvement
We developed a model for involvement that took into
account the multiple layers of a multi-site trial and
allowed active involvement in overall or specific aspects
of the trial. We included service users at the three levels:
1) strategic 2) site and 3) local. We defined strategic
level as relating to overall management of the multi-
centred trial. We defined site level as relating to one of
the three regions which constituted a study site: Wales;
London; East Midlands. We defined local level as relat-
ing to implementation of the intervention to the patient
in the community.
At Levels 1 and 2, we invited service users to be in-
volved in the structures which we set up to manage the
project:
 At Level 1, we aimed to recruit service user
members to join the strategic level study meetings –
TMG, Trial Steering Committee (TSC) and Data
Monitoring and Ethics Committee (DMEC). All trial
co-applicants and staff were invited to the TMG,
where members took decisions and oversaw study
management and implementation. The TSC and
DMEC were independent oversight groups acting on
behalf of the Project Sponsor and Project Funder to
ensure the project was conducted to a rigorous
standard. We included two service users on each of
these groups [6].
 At Level 2, we recruited service users to join a Site
Management Team (SMT) at each site to oversee
implementation and delivery of the trial by bringing
together local service users and study partners
involved with delivering the intervention and
collecting data at each site.
At Level 3, we created a Service User Reference Group
(SURG) in each site. This had not been part of the SOP
and was a new structure in our model, established in
order to liaise with service users outside the formal
management structures of the trial and provide a forum
for service user discussion and contribution to aspects
of the study.
In line with the SOP and good practice [12], we aimed
to involve 2 service users in each of these structures at
Level 1 and Level 2 and up to 10 individuals in each
SURG (Level 3). Service users could attend meetings atdifferent levels, if they wished, but TSC and DMEC
members needed to remain independent of the trial
management and implementation. We intended to in-
volve service users in research processes at all stages of
the trial: developing and planning research; data collec-
tion; analysis; and dissemination.
Recruiting and engaging service users
The complex intervention being evaluated by SAFER 2 –
to prevent recurrent falls – was targeted at older people,
who were likely to be frail or had a history of falling and
whose use of services was unplanned and urgent. In order
to identify service users (patients, carers and people at risk
of falling) with these characteristics, we linked with local or-
ganisations, charities and community groups (for example,
Stop Falls Network charity; Hackney Housebound and
Mobile Library Service; Age Concern). We asked them to
distribute information about the research opportunity and
encouraged organisers to identify potential individuals in
order to reach people with relevant experiences, appropri-
ate ages and different backgrounds. We provided training
and support to enable people to be involved and set aside
funding within the study budget to host meetings, pay
honorariums and reimburse costs incurred through in-
volvement [30].
Data collection and analysis
We collected notes of meetings and other documentary
evidence including attendance records, drafts of study pa-
pers and accounts of research tasks, to describe numbers
of service users involved, level and research processes they
were involved in, to illustrate how we implemented our
model to involve service users in the SAFER 2 trial. We
compared implementation with planned involvement to
consider issues, lessons learned and to identify areas
where service users contributed to the trial. We involved
service users from the SAFER 2 trial in writing this paper
by discussing drafts, inviting comments and including
feedback, to ensure this account accurately reflected all
experiences. Results are reported for the trial period 1
April 2009 to 23 May 2014, presenting an account of how
involvement began, how it evolved over time and how ex-
perience varied from intention. Results are presented for:
structures of involvement; recruitment and participation
by service users; and processes of involvement undertaken.
This format reflects the first two elements of the three fac-
tors – context, mechanism and outcome – whose links
should be explored when assessing public involvement in
research [23].
Results
Structures of involvement
The management structure of the SAFER 2 trial is
shown in Fig. 1. Structures which were not originally
Commissioner- HTA 
Trial management group 
Met: every 6 months 
All co applicants with key site personnel as required 
Including 2 service users 
TSC
Met: 
yearly 
Included 
2 service 
users 
DMEC
Met: 
yearly 
Included 
2 service 
users 
Core research team 
Met: Monthly 
Chief Investigator 
Trial Co managers 
Researchers 
Trial admin team (Swansea) 
Statistician if required 
Site PIs/academic leads at site 
No service users but ‘Service 
Users’ was standing agenda item 
Site researcher reported from 
Level 2 meetings 
L
ev
el
 1
 
S
tr
at
eg
ic
 t
ri
al
 m
an
ag
em
en
t 
an
d
 o
ve
rs
ig
h
t 
Task and finish groups 
Met: as needed 
Trial Manager and local 
researchers 
1 service user as required 
Writing Day 
All TMG members met to plan 
dissemination 
SMT East Midlands 
Met: Monthly 
Site PI 
Researcher 
Local stakeholders 
Local Implementation 
teams 
Trial co manager 
Service Users 
SURG East Midland 
Met: As required 
Site researcher 
Service Users 
SMT Wales 
Met: Monthly 
Site PI 
Researcher 
Local stakeholders 
Local Implementation 
teams 
Trial co manager 
Service Users 
SMT London 
Met: Monthly 
Site PI 
Researcher 
Local stakeholders 
Local Implementation 
teams 
Trial co manager 
Service Users 
SURG London 
Met: As required 
Site researcher 
Service Users 
SURG Wales 
Met: As required 
Site researcher 
Service Users 
L
ev
el
 2
 
S
it
e 
m
an
ag
em
en
t 
an
d
 im
p
le
m
en
ta
ti
o
n
 
L
ev
el
 3
 
L
o
ca
l L
ev
el
 
Key 
TMG Trial Management Group 
DMEC Data Monitoring and Ethics     
               Committee 
TSC Trial Steering Committee 
PI Principal Investigator 
SMT Site Management Team 
SURG Service User Reference  
               Group 
  New structure involving    
service users 
Fig. 1 Overall management flowchart of Support and Assessment for Fall Emergency Referrals (SAFER 2) showing structures where service users
were involved
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planned from actual arrangements. Service user in-
volvement at and within each level is shown. In
addition to the involvement structures planned at
study outset, we created Task and Finish (T&F)
Groups at strategic level and convened Writing Days
throughout the study to plan dissemination, to which
all TMG members including service users were
invited.Recruitment and participation by service users
At the strategic level (Level 1), we aimed to involve 2
service users in each meeting of the TMG, DMEC and
TSC. However, levels of participation were not consist-
ent over the 5 years, with variation in attendance and
changes in the individuals involved. Attempts to identify
a third, reserve service user to attend when a regular
member was unable, were only partially successful be-
cause service users reported they found it difficult to
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when patterns of involvement were irregular. Service
users took part in three of five T&F Groups to: discuss
ways of improving response rates to the patient ques-
tionnaires; plan and undertake qualitative analysis; hold
a one-off monitoring meeting with the HTA funder. We
also convened a group to oversee the procedural process
of gaining Research and Development permissions; and
a technical group to develop the research database. Be-
cause of the specialist and technical nature of these two
groups, we decided not to involve service users. We held
three Writing Days, attended by none, two and one ser-
vice users, respectively. The first concentrated on devel-
oping a publication plan; the second on publications for
academic journals and the final report; the third exclu-
sively on the final report.
At the site level (Level 2), service user recruitment was
challenging and attendance was inconsistent. Site re-
searchers, who were responsible for recruiting service
users to SMT meetings, found this task competed with
other research duties (including support for the SURGs).
It was also hampered by researchers’ levels of confidence
and a turn-over of site researchers during the trial and
periods between appointments when there was no site
researcher. No service users were involved in site man-
agement meetings in East Midlands. One service user
joined site management meetings in Wales in the last
year of the trial. Attendance at London site managementTable 1 Participation in involvement structures in SAFER 2
Type of meeting Number of
meetings held
Number (%) of meetin
with service users pre
Level 1: Strategic involvement
Trial Management Group (TMG) 10 8 (80%)
Trial Steering Committee (TSC) 4 (1 per annum) 3 (80%)
Data Monitoring and Ethics
Committee (DMEC)
6 (1 per annum) 6 (100%)
Task and Finish (T&F) Group 5 3 (60%)
Writing Day 3 2 (66%)
Level 2: Site level - Site Management Teams
Wales 18 4 (22%)
East Midlands 8 0
London 9 3 (33%)
Level 3: Local level - Service User Reference Groups (SURGs)
Wales SURG 1 1
East Midlands SURG 1 1
London SURG 7 7meetings was variable, with one early attendee finding
the meeting format overwhelming and attendance oner-
ous because of other caring responsibilities. This coin-
cided with the departure and replacement of the site
researcher.
At the local level (Level 3), involvement varied according
to the success of different approaches to recruiting mem-
bers to the SURGs. In Wales, the site researcher recon-
vened, for one meeting, a group which met for a previous
study on a similar topic area [29]. In East Midlands, mem-
bers of a local service user group, the Sheffield Emergency
Care Forum (see www.secf.org.uk) met once as part of
SAFER 2. In London, the site researcher used skills devel-
oped in a previous role and contacts with local charities
and service providers (Stop Falls Network charity and
Hackney Library Service) to recruit six service users
with direct and relevant experience. The group was
initiated in the third year of the study and met five
times until the study end. SURG members’ involve-
ment included helping to design data collection tools,
developing patient information and piloting patient
interviews. SURG meetings were held at universities
(Wales and East Midlands) and community venues
(London).
Participation in the 3 levels of involvement is sum-
marised in Table 1.
Study researchers reported that contacts with service
users involved in SAFER 2 increased as the researchgs
sent
Comments
Two service users were invited to each meeting
Initially, one invitee per meeting. Increased to two after second
meeting with no service user present
Also increased to two per meeting to keep consistent with TSC
Two T&F Groups considered very technical and not appropriate
for service user involvement
Service user members of TMG were invited to the writing days
One service user attended meetings in later stages of the study
No service users recruited
Initial and later service user attendance
Eight members met once. Recruited from panel co-ordinated by
Age Concern for SAFER 1 study
Four members met once. Recruited through Sheffield Emergency
Care Forum – service user group linked to Sheffield University
Six members met 7 times in years 3, 4, 5. Recruited through Falls
Prevention Service, Housing Association, mobile library service for
housebound people
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service users. Researchers identified further opportun-
ities to enable service users to contribute to the study
through the T&F Groups and Writing Days. The team
tried to make meetings as accessible as possible. We
paid honoraria and expenses, we chose accessible venues
and we always provided refreshments. Teleconferencing
and Skype were available for anyone unable to travel. Be-
cause our aim was to ensure service users could contrib-
ute to different research processes through the 3 levels
(see Table 1), we were flexible and opportunist in order to
capture and consider their views. For example, when poor
health prevented a service user member of the TMG from
attending meetings, a researcher arranged meetings at his
home to gain his views on the data collection tools under
discussion. Links between involvement levels and report-
ing mechanisms are shown in Fig. 1.
Research processes in which service users were involved
We involved service users in research processes at all
stages of the research journey: planning and managing
research; data collection; data analysis; dissemination.
Strategic and study-wide decisions such as agreeing re-
search methods, undertaking analysis and dissemination
took place at TMG or strategic T&F meetings. In-depth
discussions on recruitment, data collection and data
management at SMT meetings, and SURG meetings es-
pecially, enabled service users to contribute to the detail
of research, such as by role-playing the interview re-
spondent or suggesting ways to improve questionnaire
response rates by advising on wording on the patient
questionnaire and using coloured paper to ensure it
remained obvious and memorable to patients when
mixed within a pile of other papers. In the qualitative
analysis T&F Group, the service user received guidance
and support in order to carry out the same tasks as
other team members, reviewing data and highlighting
themes and key points for coding data. In addition to
identifying themes that were similar to those identified
by other team members, he also noted additional themes
that the research team had not identified. For example,
his patient and carer perspective prompted him to iden-
tify the cost of mobility aids as a theme emerging from
interview data. All service users were encouraged to be
involved in writing this paper, through discussions at
SURG meetings and commenting on circulated drafts, in
writing or discussion. Research processes which service
users were involved in are shown in Table 2. In some cases,
the same issues were discussed at more than one level.
Discussion
Summary of results
The SAFER 2 trial involved service users in decision-
making forums across all levels of research managementand implementation at all study sites. Service users were
involved at strategic and site levels through management
and oversight meetings; at local level through SURGs;
and additionally through other task-related meetings.
These routes allowed service users, who reflected our
vulnerable patient group, to contribute insight to re-
search tasks which researchers would not have gained
otherwise. However, involvement was uneven with vari-
ation in number and frequency of service user involve-
ment across all meetings, study levels and study
locations. Some of this was due to health and availability
of service users and we adapted ways to account for this
while maintaining our aim to achieve cross-study in-
volvement. Researcher confidence, skills, competing re-
search tasks and availability also limited where and how
much we were able to involve service users. That we
partially achieved the plan for involvement across all
three study sites raises the question of how feasible it ac-
tually was to ensure service user collaboration at every
stage and forum of the trial. Within our plan, adapted
from our CTU’s SOP for service user involvement, we
identified and implemented new opportunities for ser-
vice user involvement by creating the SURG. Our ap-
proach also evolved in response to the study context and
attitudes of researchers, so that we created service user
places in T&F Groups and at Writing Days.
Strengths and limitations
We have given a descriptive account of how we devel-
oped and implemented the SAFER 2 involvement model.
Researchers and service users have co-authored this
paper. We were not able to collect and report data about
the quality of involvement or the experiences of service
users, researchers and other partners involved in the
trial. These issues were not considered in the planning
stages of the trial and, while funding was available to ac-
tively involve service users, we did not have a budget to
assess processes and experiences concerning this aspect
of the study. Thus, we have described, but not evaluated,
our involvement model. There remains an opportunity
to assess its ability to achieve service user collaboration
in a trial and its impact on the research.
Implications for practice
Our involvement model provided a framework for ser-
vice user involvement in a multi-centre trial which can
be used in other studies. It highlighted facilitators and
barriers affecting the involvement process which we have
summarised in Table 3. The model incorporated two types
of involvement, which we call ‘inreach’ and ‘outreach’
types of involvement. In ‘inreach’ approaches, service users
were invited to become partners in the management
structures for the trial at strategic or site level. ‘Outreach’
approaches occurred when members of the research team
Table 2 Support and Assessment for Fall Emergency Referrals (SAFER 2) research processes involving service users
Research stage Research process Involvement structure
Planning and managing research Ensuring delivery of safe, high-quality research against agreed study
objectives and timescales
Level 1
TMG, DMEC, TSC
Attending the monitoring meeting by study funder Level 1
T&F one-off meeting
Reviewing site study progress against timescales Level 2
SMT
Developing research database Level 1
Data collection Developing patient questionnaire and interview schedule Level 1
TMG
Level 2
SMT
Reviewing and refining draft patient interview schedule Level 1
TMG
Level 3
SURG
Reviewing and refining draft patient questionnaires Level 3
SURG
Identifying ways to improve the completion rate of the patient consent form Level 1
T&F Group
Level 3
SURG
Piloting patient interviews Level 3
SURG
Reviewing and amending site data management challenges Level 2
SMT
Developing patient thank you letters Level 3
SURG
Analysis Reading patient transcripts to identify themes for analysis Level 1
T&F analysis Group
Coding data from patient transcripts Level 1
T&F analysis Group
Inputting into interpretation and presentation of findings from
patient interviews
Level 1
T&F analysis Group
Dissemination Commenting on drafts of final report Level 1
TMG
Contributing to papers, conference presentations and final report Level 1
Writing Day
Contributing to this paper All service users from Levels 1, 2, 3
DMEC Data Monitoring and Ethics Committee, TMG Trial Management Group, TSC Trial Steering Committee, SURG Service User Reference Group, T&F Task and
Finish, SMT Site Management Team
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local level. Links were maintained between the three levels
of involvement by the three site-based researchers and
through reporting mechanisms. The ‘inreach’ oppor-
tunities appealed to some service users, who chose toenter into the world of the research teams; for others,
the ‘outreach’ opportunities offered a chance to take
part in less formal settings and generally among their
peers. The type of setting particularly suited our hard to
reach population of older, frail, emergency ambulance
Table 3 Facilitators and barriers to involvement through the
Support and Assessment for Fall Emergency Referrals (SAFER 2)
model
Facilitators
• Model for multi-level involvement providing structure for flexible
approach which adapted to circumstances during the study
• ‘Inreach’ and ‘outreach’ involvement opportunities provided
opportunities to suit different service users’ interest and experience
• Research team support enabled implementation of model
• Service user interest and commitment supported involvement across
the study
• Site-based researchers facilitated and supported service user
involvement
• Financial resources were available to cover involvement costs
Barriers
• Service users’ health and existing commitments limited their availability
• Technical, scientific and timetable requirements in undertaking and
delivering research tempered service users’ motivation
• Continuity of involvement due to time between meetings and
fluctuating research pace across research stages hindered ability to
sustain involvement
• Changes in site researchers and time to recruit qualified replacements
reduced resources to support service user involvement leading to
involvement gaps at some levels and sites
• Research confidence, skills and competing research duties
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local champions. Having the SURGs allowed us to meet
these service users more on their terms. Our findings
echo advice from INVOLVE [21] and from Tritter and
McCallum [31] who reported: ‘effective user involvement
must be founded on connections to a multiplicity of indi-
viduals and groups and the integration of one-off and more
continuous involvement’. Rhodes et al. [32] found that hard
to reach users of diabetes services reported feeling more
able to honestly advise researchers about evaluation when
they met as a separate group.
Involving service users in trials has not been widely re-
ported despite recommendations to involve service users
in all types of studies [12, 21]. In SAFER 2, we aimed to
involve service users through collaboration by support-
ing and enabling their active involvement in trial
decision-making forums. Active involvement at all stages
of a trial is the ideal but not always practicable and feas-
ible for people experiencing poor health, unfamiliar with
academic terminology or the detail of research processes.
It has also been reported to cause stress, illness and just
be unachievable for some individuals [27, 33, 34]. The
more regular engagement in the London SURG, com-
pared to the other two areas, suggests that tailored sup-
port and facilitation skills in the research team may be
important in achieving regular attendance and input to a
trial [24, 27, 28]. Service users are a naturally diverse
population and optimal approaches to involvement willvary accordingly [35]. Our experience also confirms that
service user involvement in trials is strengthened over
time as relationships, skills and knowledge are developed
and sustained.Implications for research
Boote et al. [22] found that lack of a participatory frame-
work limited involvement in trials. The SAFER 2 model
is a framework, within which innovation (such as the
SURG) can occur, be documented and assessed. It pro-
vides a structured approach to developing knowledge
about extending and enhancing involvement in different
contexts.
Service users want to influence practice and improve
services for future patients [34, 36, 37]. In our experi-
ence, the extended periods between developing a re-
search idea, preparing and submitting a proposal and
gaining funding can frustrate and temper motivation.
Trials can take several years to complete, further testing
sustained involvement. Meanwhile, our experience sug-
gests that the process of involvement benefits from con-
tinuity over the period of a trial. The time and input
demanded of such a commitment can be onerous for pa-
tients and their carers. Future studies should prospect-
ively record and evaluate the involvement processes in a
trial to identify the most effective ways of sustaining col-
laboration and how this affects the research. Resourcing
and planning for evaluation should occur alongside
study development. Work to develop and report mea-
sures of effective involvement is advancing [25, 38–41]
and should be considered when planning, evaluating and
reporting involvement in trials.Conclusion
In the SAFER 2 trial, we have shown how it is feasible
and achievable for patients, carers and potential patients
to collaborate in a multi-centre trial of a complex inter-
vention. A standard model of involvement can be tai-
lored to suit any particular trial and a flexible approach
can assist in incorporating the complexities of a multi-
site study. Our approach allowed variations and adjust-
ments to be made to the model across study sites and
study levels. Tiers of involvement provided opportunities
for people to be involved at strategic, site or local level
where it best suited their health, location, skills and ex-
pertise. However, we found attendance at meetings was
difficult for some service users, thus showing a need for
flexibility, commitment and skills in the study team to
sustain inclusion. We offer our involvement experience
as a model for other trials to base their work on and
from which to extend and evaluate collaboration with
service users in trials.
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